On the public citation graph

From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus

0 signed · 3214 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

2 of the 200 references listed on this page are in the Retraction Watch database as retracted (export 2026-10-21): 10.1172/jci109108 (notice 1980-08-02), 10.1172/jci109394 (notice 1980-08-01).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.281.21.2005openalex-snapshot

Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus Progressive Requirement for Multiple Therapies (UKPDS 49)

inferredcites →https://doi.org/10.1001/jama.283.13.1695openalex-snapshot

Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus

inferredcites →https://doi.org/10.1001/jama.291.23.2847openalex-snapshot

Prevalence of Overweight and Obesity Among US Children, Adolescents, and Adults, 1999-2002

inferredcites →https://doi.org/10.1001/jama.296.21.joc60158openalex-snapshot

Effect of Pioglitazone Compared With Glimepiride on Carotid Intima-Media Thickness in Type 2 Diabetes

inferredcites →https://doi.org/10.1001/jama.299.13.1561openalex-snapshot

Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

inferredcites →https://doi.org/10.1002/(sici)1096-9136(199804)15:4<290::aid-dia570>3.0.co;2-mopenalex-snapshot

Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in Type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study

inferredcites →https://doi.org/10.1002/(sici)1096-9136(199804)15:4<297::aid-dia572>3.0.co;2-wopenalex-snapshot

UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years

inferredcites →https://doi.org/10.1002/0470862092openalex-snapshot

International Textbook of Diabetes Mellitus

inferredcites →https://doi.org/10.1002/0470862092.d0613openalex-snapshot

Combination Therapy in Type 2 Diabetes

inferredcites →https://doi.org/10.1002/dmr.5610010407openalex-snapshot

Physical training and insulin sensitivity

inferredcites →https://doi.org/10.1002/dmr.5610030204openalex-snapshot

Regulation of hepatic glucose metabolism in humans

inferredcites →https://doi.org/10.1002/dmr.5610040803openalex-snapshot

Metabolic basis of obesity and noninsulin‐dependent diabetes mellitus

inferredcites →https://doi.org/10.1002/dmrr.478openalex-snapshot

Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study

inferredcites →https://doi.org/10.1007/bf00265404openalex-snapshot

Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance

inferredcites →https://doi.org/10.1007/bf00274255openalex-snapshot

The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with Type 2 (non-insulin-dependent) diabetes mellitus

inferredcites →https://doi.org/10.1007/bf00285291openalex-snapshot

Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets

inferredcites →https://doi.org/10.1007/bf00297454openalex-snapshot

Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes

inferredcites →https://doi.org/10.1007/bf00400933openalex-snapshot

Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing Type 2 (non-insulin-dependent) diabetes mellitus

inferredcites →https://doi.org/10.1007/bf00404025openalex-snapshot

Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans

inferredcites →https://doi.org/10.1007/bf01219323openalex-snapshot

The relationship of insulin response to a glucose stimulus over a wide range of glucose tolerance

inferredcites →https://doi.org/10.1007/bf01228297openalex-snapshot

Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment

inferredcites →https://doi.org/10.1007/bf01338715openalex-snapshot

Peripheral glucose metabolism in control subjects and diabetic patients during glucose, glucose-insulin and insulin sensitivity tests

inferredcites →https://doi.org/10.1007/bf02369349openalex-snapshot

Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide

inferredcites →https://doi.org/10.1007/bf02427280openalex-snapshot

Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes

inferredcites →https://doi.org/10.1007/bf03340110openalex-snapshot

Insulin response during the oral glucose tolerance test: The role of age, sex, body fat and the pattern of fat distribution

inferredcites →https://doi.org/10.1007/s00125-003-1263-9openalex-snapshot

Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study

inferredcites →https://doi.org/10.1007/s00125-005-0107-1openalex-snapshot

Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005

inferredcites →https://doi.org/10.1007/s00125-005-1751-1openalex-snapshot

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes

inferredcites →https://doi.org/10.1007/s00125-006-0141-7openalex-snapshot

Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review

inferredcites →https://doi.org/10.1007/s00125-006-0176-9openalex-snapshot

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

inferredcites →https://doi.org/10.1007/s00125-006-0510-2openalex-snapshot

A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study

inferredcites →https://doi.org/10.1007/s00125-007-0698-9openalex-snapshot

Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus

inferredcites →https://doi.org/10.1007/s00125-008-1195-5openalex-snapshot

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

inferredcites →https://doi.org/10.1007/s00125-008-1256-9openalex-snapshot

Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial

inferredcites →https://doi.org/10.1007/s001250051041openalex-snapshot

Lowering fatty acids potentiates acute insulin response in first degree relatives of people with Type II diabetes

inferredcites →https://doi.org/10.1007/s001250100006openalex-snapshot

Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans

inferredcites →https://doi.org/10.1007/s001250100031openalex-snapshot

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

inferredcites →https://doi.org/10.1007/s11892-006-0034-7openalex-snapshot

Incretins and the development of type 2 diabetes

inferredcites →https://doi.org/10.1007/s11892-006-0072-1openalex-snapshot

Treatment of prediabetic neuropathy

inferredcites →https://doi.org/10.1007/s11892-008-0033-yopenalex-snapshot

Genes and type 2 diabetes mellitus

inferredcites →https://doi.org/10.1016/0006-291x(89)92529-1openalex-snapshot

Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets

inferredcites →https://doi.org/10.1016/0026-0495(77)90061-0openalex-snapshot

Spontaneous and experimental human obesity: Effects of diet and adipose cell size on lipolysis and lipogenesis

inferredcites →https://doi.org/10.1016/0026-0495(82)90163-9openalex-snapshot

Effect of long chain triglyceride infusion on glucose metabolism in man

inferredcites →https://doi.org/10.1016/0026-0495(87)90031-xopenalex-snapshot

Insulin action in non-insulin-dependent diabetes mellitus: The relationship between hepatic and extrahepatic insulin resistance and obesity

inferredcites →https://doi.org/10.1016/0026-0495(87)90051-5openalex-snapshot

Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects

inferredcites →https://doi.org/10.1016/0026-0495(88)90023-6openalex-snapshot

Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus

inferredcites →https://doi.org/10.1016/0026-0495(88)90033-9openalex-snapshot

The disposal of an oral glucose load in patients with non-insulin-dependent diabetes

inferredcites →https://doi.org/10.1016/0026-0495(89)90129-7openalex-snapshot

Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake

inferredcites →https://doi.org/10.1016/0026-0495(90)90168-copenalex-snapshot

Impaired glucose tolerance and diabetes in obesity: A 6-year follow-up study of glucose metabolism

inferredcites →https://doi.org/10.1016/0140-6736(92)92814-vopenalex-snapshot

Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study

inferredcites →https://doi.org/10.1016/1071-5576(95)00023-8openalex-snapshot

Reciprocal Variations in Insulin-Stimulated Glucose Uptake and Pancreatic Insulin Secretion in Women With Normal Glucose Tolerance

inferredcites →https://doi.org/10.1016/j.clinthera.2007.11.006openalex-snapshot

Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: A multinational, randomized, open-label, two-period, crossover noninferiority trial

inferredcites →https://doi.org/10.1016/j.cmet.2006.01.004openalex-snapshot

The biology of incretin hormones

inferredcites →https://doi.org/10.1016/j.dsx.2007.02.004openalex-snapshot

The relative contributions of insulin resistance and beta cell failure to the transition from normal to impaired glucose tolerance varies in different ethnic groups

inferredcites →https://doi.org/10.1016/j.mcna.2004.04.013openalex-snapshot

Pathogenesis of type 2 diabetes mellitus

inferredcites →https://doi.org/10.1016/j.tem.2008.08.004openalex-snapshot

Wnt signaling: relevance to β-cell biology and diabetes

inferredcites →https://doi.org/10.1016/j.ygeno.2006.03.020openalex-snapshot

A second-generation genetic linkage map of the baboon (Papio hamadryas) genome

inferredcites →https://doi.org/10.1016/s0002-9149(99)00353-7openalex-snapshot

Insulin signaling in the arterial wall

inferredcites →https://doi.org/10.1016/s0014-2999(98)00807-3openalex-snapshot

The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose

inferredcites →https://doi.org/10.1016/s0021-9258(17)41039-8openalex-snapshot

Mechanism of palmityl coenzyme A inhibition of liver glycogen synthase.

inferredcites →https://doi.org/10.1016/s0024-3205(01)01090-6openalex-snapshot

Renal glucose reabsorption during hypertonic glucose infusion in female streptozotocin-induced diabetic rats

inferredcites →https://doi.org/10.1016/s0084-3741(08)70034-9openalex-snapshot

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial

inferredcites →https://doi.org/10.1016/s0092-8674(00)80611-xopenalex-snapshot

Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1

inferredcites →https://doi.org/10.1016/s0140-6736(05)67528-9openalex-snapshot

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

inferredcites →https://doi.org/10.1016/s0140-6736(06)69420-8openalex-snapshot

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

inferredcites →https://doi.org/10.1016/s0140-6736(06)69705-5openalex-snapshot

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

inferredcites →https://doi.org/10.1016/s0140-6736(63)91500-9openalex-snapshot

THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUS

inferredcites →https://doi.org/10.1016/s0140-6736(78)91807-xopenalex-snapshot

LACK OF A GASTROINTESTINAL MEDIATOR OF INSULIN ACTION IN MATURITY-ONSET DIABETES

inferredcites →https://doi.org/10.1016/s0140-6736(89)92804-3openalex-snapshot

SEQUENTIAL CHANGES IN SERUM INSULIN CONCENTRATION DURING DEVELOPMENT OF NON-INSULIN-DEPENDENT DIABETES

inferredcites →https://doi.org/10.1016/s0140-6736(98)07019-6openalex-snapshot

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

inferredcites →https://doi.org/10.1016/s0140-6736(98)07037-8openalex-snapshot

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

inferredcites →https://doi.org/10.1016/s0149-2918(00)83039-8openalex-snapshot

Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study

inferredcites →https://doi.org/10.1016/s1047-2797(98)00002-7openalex-snapshot

Ability of Alternative Indices of Insulin Sensitivity to Predict Cardiovascular Risk

inferredcites →https://doi.org/10.1016/s1071-3581(03)00520-8openalex-snapshot

Metabolic and molecular basis of insulin resistance

inferredcites →https://doi.org/10.1038/35007534openalex-snapshot

Central nervous system control of food intake

inferredcites →https://doi.org/10.1038/414799aopenalex-snapshot

Insulin signalling and the regulation of glucose and lipid metabolism

inferredcites →https://doi.org/10.1038/ng0703-244openalex-snapshot

PGC-1α at the crossroads of type 2 diabetes

inferredcites →https://doi.org/10.1038/ng1180openalex-snapshot

PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

inferredcites →https://doi.org/10.1038/ng1732openalex-snapshot

Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes

inferredcites →https://doi.org/10.1038/ng1960openalex-snapshot

Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution

inferredcites →https://doi.org/10.1038/ng2043openalex-snapshot

A variant in CDKAL1 influences insulin response and risk of type 2 diabetes

inferredcites →https://doi.org/10.1038/nn0602-861openalex-snapshot

Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats

inferredcites →https://doi.org/10.1038/nrm1837openalex-snapshot

Critical nodes in signalling pathways: insights into insulin action

inferredcites →https://doi.org/10.1038/sj.ijo.0802625openalex-snapshot

Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients

inferredcites →https://doi.org/10.1042/cs0820219openalex-snapshot

Effect of increased free fatty acid supply on glucose metabolism and skeletal muscle glycogen synthase activity in normal man

inferredcites →https://doi.org/10.1046/j.1365-2362.2002.00931.xopenalex-snapshot

Oxysterols induce interleukin‐1β production in human macrophages

inferredcites →https://doi.org/10.1046/j.1365-2362.32.s3.3.xopenalex-snapshot

Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction

inferredcites →https://doi.org/10.1046/j.1365-2362.32.s3.5.xopenalex-snapshot

The evolution of β‐cell dysfunction and insulin resistance in type 2 diabetes

inferredcites →https://doi.org/10.1053/meta.2002.34700openalex-snapshot

Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals

inferredcites →https://doi.org/10.1056/nejm198805123181901openalex-snapshot

Impaired Glucose Tolerance as a Disorder of Insulin Action

inferredcites →https://doi.org/10.1056/nejm198812083192302openalex-snapshot

The Natural History of Impaired Glucose Tolerance in the Pima Indians

inferredcites →https://doi.org/10.1056/nejm198908103210601openalex-snapshot

Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes Mellitus

inferredcites →https://doi.org/10.1056/nejm198908243210806openalex-snapshot

Islet Amyloid, Islet-Amyloid Polypeptide, and Diabetes Mellitus

inferredcites →https://doi.org/10.1056/nejm199001253220403openalex-snapshot

Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance Spectroscopy

inferredcites →https://doi.org/10.1056/nejm199312303292703openalex-snapshot

Insulin Resistance and Insulin Secretory Dysfunction as Precursors of Non-Insulin-Dependent Diabetes Mellitus: Prospective Studies of Pima Indians

inferredcites →https://doi.org/10.1056/nejm199508313330902openalex-snapshot

Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus

inferredcites →https://doi.org/10.1056/nejm199803263381303openalex-snapshot

Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus

inferredcites →https://doi.org/10.1056/nejm199907223410404openalex-snapshot

Impaired Glucose Transport as a Cause of Decreased Insulin-Stimulated Muscle Glycogen Synthesis in Type 2 Diabetes

inferredcites →https://doi.org/10.1056/nejmoa060326openalex-snapshot

A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis

inferredcites →https://doi.org/10.1056/nejmoa066224openalex-snapshot

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

inferredcites →https://doi.org/10.1056/nejmoa075392openalex-snapshot

Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes

inferredcites →https://doi.org/10.1056/nejmra041001openalex-snapshot

Thiazolidinediones

inferredcites →https://doi.org/10.1073/pnas.0401401101openalex-snapshot

Errα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle

inferredcites →https://doi.org/10.1073/pnas.1032913100openalex-snapshot

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

inferredcites →https://doi.org/10.1073/pnas.56.1.247openalex-snapshot

Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver.

inferredcites →https://doi.org/10.1073/pnas.75.10.5173openalex-snapshot

Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange

inferredcites →https://doi.org/10.1073/pnas.92.4.983openalex-snapshot

Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus.

inferredcites →https://doi.org/10.1073/pnas.96.20.11513openalex-snapshot

Troglitazone prevents mitochondrial alterations, β cell destruction, and diabetes in obese prediabetic rats

inferredcites →https://doi.org/10.1074/jbc.273.6.3547openalex-snapshot

Troglitazone Lowers Islet Fat and Restores Beta Cell Function of Zucker Diabetic Fatty Rats

inferredcites →https://doi.org/10.1074/jbc.m103702200openalex-snapshot

Insulin-stimulated Activation of eNOS Is Independent of Ca2+ but Requires Phosphorylation by Akt at Ser1179

inferredcites →https://doi.org/10.1074/jbc.m200958200openalex-snapshot

Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle

inferredcites →https://doi.org/10.1074/jbc.m408985200openalex-snapshot

Lipid Infusion Decreases the Expression of Nuclear Encoded Mitochondrial Genes and Increases the Expression of Extracellular Matrix Genes in Human Skeletal Muscle

inferredcites →https://doi.org/10.1097/00005792-196311000-00002openalex-snapshot

ROLES OF INSULIN AND GROWTH HORMONE, BASED ON STUDIES ON FOREARM METABOLISM IN MAN

inferredcites →https://doi.org/10.1111/j.1368-504x.2004.00389.xopenalex-snapshot

Dysfunctional fat cells, lipotoxicity and type 2 diabetes

inferredcites →https://doi.org/10.1111/j.1463-1326.2005.00541.xopenalex-snapshot

Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study

inferredcites →https://doi.org/10.1111/j.1463-1326.2008.00880.xopenalex-snapshot

Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients

inferredcites →https://doi.org/10.1111/j.1464-5491.2007.02043.xopenalex-snapshot

The prevalence of retinopathy in impaired glucose tolerance and recent‐onset diabetes in the Diabetes Prevention Program

inferredcites →https://doi.org/10.1111/j.1464-5491.2007.02160.xopenalex-snapshot

Rosiglitazone RECORD study: glucose control outcomes at 18 months

inferredcites →https://doi.org/10.1111/j.1467-789x.2007.00432.xopenalex-snapshot

The fundamental drivers of the obesity epidemic

inferredcites →https://doi.org/10.1111/j.1532-5415.1982.tb05662.xopenalex-snapshot

Effect of Age on Glucose Tolerance, Insulin Secretion, and in Vivo Insulin Action

inferredcites →https://doi.org/10.1126/science.289.5487.2122openalex-snapshot

Role of Brain Insulin Receptor in Control of Body Weight and Reproduction

inferredcites →https://doi.org/10.1136/bmj.282.6277.1656openalex-snapshot

Metabolic studies in unaffected co-twins of non-insulin-dependent diabetics.

inferredcites →https://doi.org/10.1152/ajpendo.00030.2008openalex-snapshot

Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes

inferredcites →https://doi.org/10.1152/ajpendo.00366.2002openalex-snapshot

Aging and insulin secretion

inferredcites →https://doi.org/10.1152/ajpendo.00541.2003openalex-snapshot

Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes

inferredcites →https://doi.org/10.1152/ajpendo.00545.2003openalex-snapshot

Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans

inferredcites →https://doi.org/10.1152/ajpendo.00551.2006openalex-snapshot

Thiazolidinediones improve β-cell function in type 2 diabetic patients

inferredcites →https://doi.org/10.1152/ajpendo.00561.2002openalex-snapshot

Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARγ2 in the modulation of insulin secretion

inferredcites →https://doi.org/10.1152/ajpendo.00617.2005openalex-snapshot

Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals

inferredcites →https://doi.org/10.1152/ajpendo.1979.237.3.e214openalex-snapshot

Glucose clamp technique: a method for quantifying insulin secretion and resistance.

inferredcites →https://doi.org/10.1152/ajpendo.1995.269.4.e701openalex-snapshot

Regulation of hexokinase II and glycogen synthase mRNA, protein, and activity in human muscle

inferredcites →https://doi.org/10.1152/ajpendo.1996.270.3.e463openalex-snapshot

Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM

inferredcites →https://doi.org/10.1152/ajpendo.2000.279.3.e554openalex-snapshot

Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle

inferredcites →https://doi.org/10.1152/ajpendo.2001.280.2.e229openalex-snapshot

DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells

inferredcites →https://doi.org/10.1152/ajpendo.90222.2008openalex-snapshot

Exenatide can reduce glucose independent of islet hormones or gastric emptying

inferredcites →https://doi.org/10.1152/ajpendo.90287.2008openalex-snapshot

Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance

inferredcites →https://doi.org/10.1152/ajprenal.1994.266.2.f283openalex-snapshot

Molecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats

inferredcites →https://doi.org/10.1159/000022865openalex-snapshot

Familiality of Quantitative Metabolic Traits in Finnish Families with Non-Insulin-Dependent Diabetes mellitus

inferredcites →https://doi.org/10.1159/000135410openalex-snapshot

Effects of Fat Infusion on Glucose Tolerance and Insulin Plasma Levels

inferredcites →https://doi.org/10.1159/000353879openalex-snapshot

Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities

inferredcites →https://doi.org/10.1159/000444053openalex-snapshot

Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children

inferredcites →https://doi.org/10.1172/jci0214955openalex-snapshot

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

inferredcites →https://doi.org/10.1172/jci106297openalex-snapshot

Studies of pancreatic alpha cell function in normal and diabetic subjects

inferredcites →https://doi.org/10.1172/jci107625openalex-snapshot

Glucose Metabolism and the Response to Insulin by Human Adipose Tissue in Spontaneous and Experimental Obesity

inferredcites →https://doi.org/10.1172/jci109108openalex-snapshot

Insulin Binding to Monocytes and Insulin Action in Human Obesity, Starvation, and Refeeding

inferredcites →https://doi.org/10.1172/jci109394openalex-snapshot

Insulin Sensitivity and Insulin Binding to Monocytes in Maturity-Onset Diabetes

inferredcites →https://doi.org/10.1172/jci110350openalex-snapshot

Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.

inferredcites →https://doi.org/10.1172/jci111133openalex-snapshot

Effect of fatty acids on glucose production and utilization in man.

inferredcites →https://doi.org/10.1172/jci111533openalex-snapshot

Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.

inferredcites →https://doi.org/10.1172/jci111938openalex-snapshot

Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.

inferredcites →https://doi.org/10.1172/jci112078openalex-snapshot

Mechanism of liver glycogen repletion in vivo by nuclear magnetic resonance spectroscopy.

inferredcites →https://doi.org/10.1172/jci112389openalex-snapshot

Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions.

inferredcites →https://doi.org/10.1172/jci113118openalex-snapshot

Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism.

inferredcites →https://doi.org/10.1172/jci113157openalex-snapshot

Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.

inferredcites →https://doi.org/10.1172/jci113572openalex-snapshot

Relationship between plasma glucose and insulin concentration, glucose production, and glucose disposal in normal subjects and patients with non-insulin-dependent diabetes.

inferredcites →https://doi.org/10.1172/jci114142openalex-snapshot

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.

inferredcites →https://doi.org/10.1172/jci114940openalex-snapshot

Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism.

inferredcites →https://doi.org/10.1172/jci115686openalex-snapshot

31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus.

inferredcites →https://doi.org/10.1172/jci115997openalex-snapshot

Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study.

inferredcites →https://doi.org/10.1172/jci116186openalex-snapshot

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

inferredcites →https://doi.org/10.1172/jci117715openalex-snapshot

Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.

inferredcites →https://doi.org/10.1172/jci118742openalex-snapshot

Mechanism of free fatty acid-induced insulin resistance in humans.

inferredcites →https://doi.org/10.1172/jci12954openalex-snapshot

Central melanocortin receptors regulate insulin action

inferredcites →https://doi.org/10.1172/jci13505openalex-snapshot

Role of AMP-activated protein kinase in mechanism of metformin action

inferredcites →https://doi.org/10.1172/jci14955openalex-snapshot

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

inferredcites →https://doi.org/10.1172/jci25151openalex-snapshot

Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents

inferredcites →https://doi.org/10.1172/jci29063openalex-snapshot

Central insulin action in energy and glucose homeostasis

inferredcites →https://doi.org/10.1172/jci29103openalex-snapshot

Islet cell failure in type 2 diabetes

inferredcites →https://doi.org/10.1172/jci30706openalex-snapshot

Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes

inferredcites →https://doi.org/10.1172/jci5001openalex-snapshot

Effects of free fatty acids on glucose transport and IRS-1–associated phosphatidylinositol 3-kinase activity

inferredcites →https://doi.org/10.1172/jci716openalex-snapshot

Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.

inferredcites →https://doi.org/10.1172/jci7535openalex-snapshot

Insulin resistance differentially affects the PI 3-kinase– and MAP kinase–mediated signaling in human muscle

inferredcites →https://doi.org/10.1185/030079906x112598openalex-snapshot

Glycemic control and treatment failure with pioglitazone versus glibenclamide in type 2 diabetes mellitus: a 42-month, open-label, observational, primary care study

inferredcites →https://doi.org/10.1185/030079908x253870openalex-snapshot

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

inferredcites →https://doi.org/10.1186/1472-6823-9-17openalex-snapshot

Actos Now for the prevention of diabetes (ACT NOW) study

inferredcites →https://doi.org/10.1210/en.2003-0323openalex-snapshot

Glucagon-Like Peptide 1 Inhibits Cell Apoptosis and Improves Glucose Responsiveness of Freshly Isolated Human Islets

inferredcites →https://doi.org/10.1210/en.2003-0939openalex-snapshot

Activation of the Hexosamine Pathway Leads to Phosphorylation of Insulin Receptor Substrate-1 on Ser307 and Ser612 and Impairs the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Insulin Biosynthetic Pathway in RIN Pancreatic β-Cells

inferredcites →https://doi.org/10.1210/er.2002-0012openalex-snapshot

Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α (PGC-1α): Transcriptional Coactivator and Metabolic Regulator

inferredcites →https://doi.org/10.1210/er.2007-0037openalex-snapshot

Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis

inferredcites →https://doi.org/10.1210/jc.2003-030723openalex-snapshot

Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach

inferredcites →https://doi.org/10.1210/jc.2004-0745openalex-snapshot

Insulin Resistance Is Associated with Impaired Nitric Oxide Synthase Activity in Skeletal Muscle of Type 2 Diabetic Subjects

inferredcites →https://doi.org/10.1210/jc.2004-1133openalex-snapshot

β-Cell Function in Subjects Spanning the Range from Normal Glucose Tolerance to Overt Diabetes: A New Analysis

inferredcites →https://doi.org/10.1210/jc.2005-0079openalex-snapshot

Activation of Peroxisome Proliferator-Activated Receptor-γ by Rosiglitazone Protects Human Islet Cells against Human Islet Amyloid Polypeptide Toxicity by a Phosphatidylinositol 3′-Kinase-Dependent Pathway

inferredcites →https://doi.org/10.1210/jc.2005-1159openalex-snapshot

The Effect of Rosiglitazone on the Liver: Decreased Gluconeogenesis in Patients with Type 2 Diabetes

inferredcites →https://doi.org/10.1210/jc.2006-1882openalex-snapshot

The Dipeptidyl Peptidase IV Inhibitor Vildagliptin Suppresses Endogenous Glucose Production and Enhances Islet Function after Single-Dose Administration in Type 2 Diabetic Patients

inferredcites →https://doi.org/10.1210/jc.81.11.4059openalex-snapshot

Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus

inferredcites →https://doi.org/10.1210/jc.81.5.1846openalex-snapshot

Insulin secretion and resistance in nondiabetic Mexican Americans and non-Hispanic whites with a parental history of diabetes

inferredcites →https://doi.org/10.1210/jc.83.1.230openalex-snapshot

Effects of Insulin on Subcellular Localization of Hexokinase II in Human Skeletal Muscle in Vivo

inferredcites →https://doi.org/10.1210/jc.86.8.3717openalex-snapshot

Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients

inferredcites →https://doi.org/10.1210/jc.87.6.2784openalex-snapshot

Effect of Pioglitazone on Abdominal Fat Distribution and Insulin Sensitivity in Type 2 Diabetic Patients

inferredcites →https://doi.org/10.1210/jcem-61-5-807openalex-snapshot

Ambient Plasma Free Fatty Acid Concentrations in Noninsulin-Dependent Diabetes Mellitus: Evidence for Insulin Resistance*

inferredcites →https://doi.org/10.1210/jcem-64-1-106openalex-snapshot

Documentation of Hyperglucagonemia Throughout the Day in Nonobese and Obese Patients with Noninsulin-Dependent Diabetes Mellitus*

inferredcites →https://doi.org/10.1210/jcem-72-1-96openalex-snapshot

The Role of Free Fatty Acid Metabolism in the Pathogenesis of Insulin Resistance in Obesity and Noninsulin-Dependent Diabetes Mellitus*

inferredcites →https://doi.org/10.1371/journal.pmed.0020233openalex-snapshot

Decreased Insulin-Stimulated ATP Synthesis and Phosphate Transport in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Parents

inferredcites →https://doi.org/10.1385/endo:29:1:73openalex-snapshot

Insulin Resistance and Improvements in Signal Transduction

inferredcites →https://doi.org/10.1517/13543784.16.4.533openalex-snapshot

Dipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for Type 2 diabetes

inferredcites →https://doi.org/10.1586/14779072.6.3.343openalex-snapshot

Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity

inferredcites →https://doi.org/10.1586/17446651.1.3.329openalex-snapshot

Exenatide: first-in-class incretin mimetic for the treatment of Type 2 diabetes mellitus

inferredcites →https://doi.org/10.1681/asn.v86943openalex-snapshot

Overexpression of GLUT2 gene in renal proximal tubules of diabetic Zucker rats.

inferredcites →https://doi.org/10.2337/db05-1200openalex-snapshot

Insulin Secretion and Action in Subjects With Impaired Fasting Glucose and Impaired Glucose Tolerance

showing the first 200 of 297

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4073615openalex-extracted

inferred← citeshttps://doi.org/10.2139/ssrn.4533824openalex-extracted

Effects of New Iridoids in Patrinia Punctiflora on Insulin Resistance in Hepg2 Cells

inferred← citeshttps://doi.org/10.1001/jama.2011.207openalex-snapshot

Functional Variants of the HMGA1 Gene and Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1001/jama.2014.5951openalex-snapshot

Insulin Therapy for Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1001/jama.2023.4063openalex-snapshot

Diagnosis and Management of Prediabetes

inferred← citeshttps://doi.org/10.1001/jamainternmed.2016.1540openalex-snapshot

Effect of Adding Liraglutide vs Placebo to a High-Dose lnsulin Regimen in Patients With Type 2 Diabetes

inferred← citeshttps://doi.org/10.1002/14651858.cd016380openalex-snapshot

Glucagon-like peptide-1 receptor agonist-based regimens compared with metformin-based regimens for preventing cardiovascular disease in adults with type 2 diabetes mellitus

inferred← citeshttps://doi.org/10.1002/9780470910016.ch17openalex-snapshot

Monoclonal Antibodies for the Treatment of Type 2 Diabetes: A Case Study with Glucagon Receptor Blockade

inferred← citeshttps://doi.org/10.1002/9781118354483.ch6openalex-snapshot

Diabetes Drugs

inferred← citeshttps://doi.org/10.1002/9781118387658.ch14openalex-snapshot

Insulin actions in vivo : glucose metabolism

inferred← citeshttps://doi.org/10.1002/9781118387658.ch25openalex-snapshot

Pathogenesis of type 2 diabetes mellitus

inferred← citeshttps://doi.org/10.1002/9781118387658.ch46openalex-snapshot

Combination therapy in type 2 diabetes mellitus

inferred← citeshttps://doi.org/10.1002/9781118387658.ch47openalex-snapshot

New drugs for the treatment of diabetes mellitus

inferred← citeshttps://doi.org/10.1002/9781118387658.ch55openalex-snapshot

Type 2 diabetes in obese adolescents: pathophysiology and treatment

inferred← citeshttps://doi.org/10.1002/9781118467831.ch11openalex-snapshot

Disruption of Circadian Rhythms and Development of Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1002/9781118857991.ch2openalex-snapshot

Consequences and comorbidities associated with obesity

inferred← citeshttps://doi.org/10.1002/9781118924853.ch31openalex-snapshot

Oral Glucose‐Lowering Agents

inferred← citeshttps://doi.org/10.1002/9781118924853.ch33openalex-snapshot

How to Use Type 2 Diabetes Treatments in Clinical Practice: Combination Therapies

inferred← citeshttps://doi.org/10.1002/9781118924853.ch67openalex-snapshot

Future Drug Treatments for Type 2 Diabetes

inferred← citeshttps://doi.org/10.1002/9781118954621.ch1openalex-snapshot

Pathophysiology of diabetes in older people

inferred← citeshttps://doi.org/10.1002/9781118954621.ch15openalex-snapshot

Insulin resistance and the metabolic syndrome

inferred← citeshttps://doi.org/10.1002/9781119783435.ch24openalex-snapshot

CO and Diabetes

inferred← citeshttps://doi.org/10.1002/9781119904786.ch12openalex-snapshot

Novel Therapeutic Strategies Targeting Gut Microbiota to Treat Diseases

inferred← citeshttps://doi.org/10.1002/9781119949893.ch8openalex-snapshot

Coffee and Type 2 Diabetes Risk

inferred← citeshttps://doi.org/10.1002/9783527676545.ch09openalex-snapshot

From Natural Product to New Diabetes Therapy: Phlorizin and the Discovery of SGLT2 Inhibitor Clinical Candidates

inferred← citeshttps://doi.org/10.1002/biof.1253openalex-snapshot

Effect of chromium picolinate and melatonin either in single or in a combination in high carbohydrate diet‐fed male Wistar rats

inferred← citeshttps://doi.org/10.1002/brb3.71210openalex-snapshot

Case–Controlled Clinical Assessment of the Olfactory System via Cranial Magnetic Resonance Imaging in Patients With Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1002/cbf.1789openalex-snapshot

The effects of hypercaloric diets on glucose homeostasis in the rat: influence of saturated and monounsaturated dietary lipids

inferred← citeshttps://doi.org/10.1002/cpdd.276openalex-snapshot

Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Piragliatin, a Glucokinase Activator, and Glyburide, a Sulfonylurea, in Type 2 Diabetic Patients

inferred← citeshttps://doi.org/10.1002/cpdd.289openalex-snapshot

Dose‐Dependent Effect of Piragliatin, a Glucokinase Activator, on the QT Interval Following Short‐Term Multiple Doses in Patients With Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1002/cpdd.70029openalex-snapshot

Bioequivalence Evaluation of Two Metformin/Empagliflozin Fixed‐Dose Combination Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions: A Randomized, Open‐Label, Crossover Study

inferred← citeshttps://doi.org/10.1002/cphy.c170010openalex-snapshot

Structure and Function of Bone Marrow Adipocytes

inferred← citeshttps://doi.org/10.1002/cphy.c220031openalex-snapshot

Noncanonical Regulation of cAMP‐Dependent Insulin Secretion and Its Implications in Type 2 Diabetes

inferred← citeshttps://doi.org/10.1002/cpt.125openalex-snapshot

Safety of antidiabetes medications: An update

inferred← citeshttps://doi.org/10.1002/cpt.144openalex-snapshot

The Current Drug Treatment Landscape for Diabetes and Perspectives for the Future

inferred← citeshttps://doi.org/10.1002/cpt.998openalex-snapshot

Development and Qualification of a Drug‐Disease Modeling Platform to Characterize Clinically Relevant Endpoints in Type 2 Diabetes Trials

inferred← citeshttps://doi.org/10.1002/ddr.21859openalex-snapshot

Chrysin modulates protein kinase IKKε / TBK1 , insulin sensitivity and hepatic fatty infiltration in diet‐induced obese mice

inferred← citeshttps://doi.org/10.1002/dmrr.1037openalex-snapshot

Current literature in diabetes

inferred← citeshttps://doi.org/10.1002/dmrr.1135openalex-snapshot

Novel insights into the relationship between diabetes and osteoporosis

inferred← citeshttps://doi.org/10.1002/dmrr.1174openalex-snapshot

Insulin therapy has a complex relationship with measure of oxidative stress in type 2 diabetes: a case for further study

inferred← citeshttps://doi.org/10.1002/dmrr.1185openalex-snapshot

Effects of insulin and oral anti‐diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects

inferred← citeshttps://doi.org/10.1002/dmrr.2350openalex-snapshot

Second line therapy: type 2 diabetic subjects failing on metformin GLP‐1/DPP‐IV inhibitors versus sulphonylurea/insulin: For GLP‐1/DPP‐IV inhibitors

inferred← citeshttps://doi.org/10.1002/dmrr.2599openalex-snapshot

Circulating SFRP5 levels are elevated in drug‐naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls

inferred← citeshttps://doi.org/10.1002/dmrr.2770openalex-snapshot

Utility of serum lipid ratios for predicting incident type 2 diabetes: the Isfahan Diabetes Prevention Study

inferred← citeshttps://doi.org/10.1002/dmrr.2810openalex-snapshot

Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program

inferred← citeshttps://doi.org/10.1002/dmrr.2986openalex-snapshot

Ten‐year weight gain is associated with elevated fasting insulin levels and precedes glucose elevation

inferred← citeshttps://doi.org/10.1002/dmrr.3050openalex-snapshot

Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes

inferred← citeshttps://doi.org/10.1002/dmrr.3371openalex-snapshot

Obesity and impairment of pancreatic β ‐cell function in early adulthood, independent of obesity age of onset: The Santiago Longitudinal Study

inferred← citeshttps://doi.org/10.1002/dmrr.3558openalex-snapshot

Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10

inferred← citeshttps://doi.org/10.1002/dmrr.3609openalex-snapshot

Glucagon in type 2 diabetes: Friend or foe?

inferred← citeshttps://doi.org/10.1002/dmrr.3711openalex-snapshot

Early treatment with dipeptidyl‐peptidase 4 inhibitors reduces glycaemic variability and delays insulin initiation in type 2 diabetes: A propensity score‐matched cohort study

inferred← citeshttps://doi.org/10.1002/dmrr.70029openalex-snapshot

The Rise of Type 2 Diabetes in Children and Adolescents: An Emerging Pandemic

inferred← citeshttps://doi.org/10.1002/edm2.100openalex-snapshot

Risk of any hypoglycaemia with newer antihyperglycaemic agents in patients with type 2 diabetes: A systematic review and meta‐analysis

inferred← citeshttps://doi.org/10.1002/edm2.107openalex-snapshot

Dose distribution and up‐titration patterns of metformin monotherapy in patients with type 2 diabetes

inferred← citeshttps://doi.org/10.1002/edm2.70061openalex-snapshot

Efficacy and Safety of Pioglitazone Add‐On in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials

inferred← citeshttps://doi.org/10.1002/eji.201847895openalex-snapshot

‘Beauty and the beast’ in infection: How immune–endocrine interactions regulate systemic metabolism in the context of infection

inferred← citeshttps://doi.org/10.1002/fsn3.70469openalex-snapshot

Therapeutic Potential of Lavandula stoechas Aqueous Extract in Managing Diabetes and Its Complications: Insights From Biochemical and In Silico Studies

inferred← citeshttps://doi.org/10.1002/j.2040-4603.2018.tb00007.xopenalex-snapshot

Structure and Function of Bone Marrow Adipocytes

inferred← citeshttps://doi.org/10.1002/j.2040-4603.2023.tb00278.xopenalex-snapshot

Noncanonical Regulation of cAMP‐Dependent Insulin Secretion and Its Implications in Type 2 Diabetes

inferred← citeshttps://doi.org/10.1002/jcb.26362openalex-snapshot

Loureirin B promotes insulin secretion through inhibition of KATP channel and influx of intracellular calcium

inferred← citeshttps://doi.org/10.1002/jcb.30376openalex-snapshot

Dexamethasone leads to Zn2+ accumulation and increased unbound Zn2+ in C2C12 muscle and 3T3‐L1 adipose cells

inferred← citeshttps://doi.org/10.1002/jcla.24693openalex-snapshot

The usefulness of the estimated average glucose/fasting blood glucose ratio for pancreatic β‐cell function assessment in hyperglycemia during health checkups

inferred← citeshttps://doi.org/10.1002/jcp.27556openalex-snapshot

Punicic acid: A potential compound of pomegranate seed oil in Type 2 diabetes mellitus management

inferred← citeshttps://doi.org/10.1002/jcph.192openalex-snapshot

A drug and disease model for lixisenatide, a GLP‐1 receptor agonist in type 2 diabetes

inferred← citeshttps://doi.org/10.1002/jcph.589openalex-snapshot

Effects of piragliatin, a glucokinase activator, on fasting and postprandial plasma glucose in patients with type 2 diabetes mellitus

inferred← citeshttps://doi.org/10.1002/jcph.617openalex-snapshot

Exploratory effects of a strong CYP3A inhibitor (ketoconazole), a strong CYP3A inducer (rifampicin), and concomitant ethanol on piragliatin pharmacokinetics and pharmacodynamics in type 2 diabetic patients

inferred← citeshttps://doi.org/10.1002/jcph.640openalex-snapshot

Lack of Potential Pharmacokinetic and Pharmacodynamic Interactions Between Piragliatin, a Glucokinase Activator, and Simvastatin in Patients With Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1002/jcph.88openalex-snapshot

Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co‐Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1002/jcsm.12841openalex-snapshot

Systemic ablation of vitamin D receptor leads to skeletal muscle glycogen storage disorder in mice

inferred← citeshttps://doi.org/10.1002/jgf2.58openalex-snapshot

A periodontal disease care program for patients with type 2 diabetes: A randomized controlled trial

inferred← citeshttps://doi.org/10.1002/lipd.12337openalex-snapshot

Lipid profile, lipid ratios, apolipoproteins, and risk of cardiometabolic multimorbidity in men: The Kuopio Ischaemic Heart Disease Risk Factor Study

inferred← citeshttps://doi.org/10.1002/mnfr.201300223openalex-snapshot

Overview of food products and dietary constituents with antidiabetic properties and their putative mechanisms of action: A natural approach to complement pharmacotherapy in the management of diabetes

inferred← citeshttps://doi.org/10.1002/mnfr.202200106openalex-snapshot

Anti‐Diabetic Intestinal Mechanisms: Foods, Herbs, and Western Medicines

inferred← citeshttps://doi.org/10.1002/msc.70154openalex-snapshot

Effectiveness of a Supervised 8‐Week Structured Intensive Exercise Protocol on Functional Performance and Physiological Parameters in Adults With Obesity—An Experimental Study

inferred← citeshttps://doi.org/10.1002/nau.24491openalex-snapshot

Impact of gestational diabetes on pelvic floor: A prospective cohort study with three‐dimensional ultrasound during two‐time points in pregnancy

inferred← citeshttps://doi.org/10.1002/nep3.70008openalex-snapshot

Beta cells to brain cells: The pivotal role of insulin and glucose metabolism in Alzheimer's disease

inferred← citeshttps://doi.org/10.1002/oby.23363openalex-snapshot

Insulin sensitivity and kinetics in African American and White people with obesity: Insights from different study protocols

inferred← citeshttps://doi.org/10.1002/open.70299openalex-snapshot

Integrative In Silico Profiling of Major Phytochemicals From a Sclerocarya birrea–Nauclea latifolia–Piper longum Mixture: Docking, Molecular Dynamics, ADMET, and Ligand‐Based Target Prediction on Shared Pathways in Type 2 Diabetes Mellitus and Alzheimer's Disease

inferred← citeshttps://doi.org/10.1002/pdi.2109openalex-snapshot

Novel therapies in type 2 diabetes: insulin resistance

inferred← citeshttps://doi.org/10.1002/pdi.2337openalex-snapshot

Effect of whole body vibration on clinical and metabolic outcomes in adults with type 2 diabetes: an observational pilot trial

inferred← citeshttps://doi.org/10.1002/pds.5583openalex-snapshot

Identification of polypharmacy patterns in new‐users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining

inferred← citeshttps://doi.org/10.1002/prca.201800104openalex-snapshot

Stearate‐Induced Apoptosis in Human Pancreatic β‐Cells is Associated with Changes in Membrane Protein Expression and These Changes are Inhibited by Oleate

inferred← citeshttps://doi.org/10.1002/prp2.1043openalex-snapshot

Selective somatostatin receptor 5 inhibition improves hepatic insulin sensitivity

inferred← citeshttps://doi.org/10.1002/psb.1355openalex-snapshot

Type 2 diabetes: recent advances in diagnosis and management

inferred← citeshttps://doi.org/10.1002/ptr.7454openalex-snapshot

The role of Pycnogenol in the control of inflammation and oxidative stress in chronic diseases: Molecular aspects

inferred← citeshttps://doi.org/10.1002/ptr.8067openalex-snapshot

Polysaccharides (pectin, mucilage, and fructan inulin) and their fermented products: A critical analysis of their biochemical, gut interactions, and biological functions as antidiabetic agents

inferred← citeshttps://doi.org/10.1002/ptr.8281openalex-snapshot

Natural hypoglycaemic bioactives: Newer avenues and newer possibilities

inferred← citeshttps://doi.org/10.1002/slct.202101589openalex-snapshot

Discovery of Novel G‐Protein‐Coupled Receptor 40 Agonist with Phenylacetic Acid Scaffold for the Treatment of Type 2 Diabetes

inferred← citeshttps://doi.org/10.1002/slct.202104199openalex-snapshot

Design, synthesis, and biological evaluation of novel FFA1 partial agonists bearing oxime ether scaffold**

inferred← citeshttps://doi.org/10.1007/164_2026_828openalex-snapshot

Physiology of Kidney Glucose Transport and Mechanisms of Kidney Protection by SGLT2 Inhibitors

inferred← citeshttps://doi.org/10.1007/5584_2020_516openalex-snapshot

Glucose Lowering Treatment Modalities of Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1007/5584_2020_518openalex-snapshot

Diabetes and Genetics: A Relationship Between Genetic Risk Alleles, Clinical Phenotypes and Therapeutic Approaches

inferred← citeshttps://doi.org/10.1007/978-0-387-09841-8_34openalex-snapshot

Insulin Resistance and the Metabolic Syndrome

inferred← citeshttps://doi.org/10.1007/978-0-387-09841-8_44openalex-snapshot

Treating Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1007/978-1-0716-0385-7_15openalex-snapshot

Assessment of Insulin Tolerance In Vivo in Mice

inferred← citeshttps://doi.org/10.1007/978-1-4471-2366-8_4openalex-snapshot

Metabolic Syndrome in Childhood as a Risk Factor for Type 2 Diabetes

inferred← citeshttps://doi.org/10.1007/978-1-4471-2828-1_6openalex-snapshot

Diabetes and Heart Disease

inferred← citeshttps://doi.org/10.1007/978-1-4614-1028-7_8openalex-snapshot

Management of Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1007/978-1-4614-5441-0_13openalex-snapshot

Glycemic Variability in Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1007/978-1-4614-7554-5_2openalex-snapshot

Lipoprotein Subclasses and Cardiovascular Disease Risk in Insulin-Resistant Diabetes

inferred← citeshttps://doi.org/10.1007/978-1-4939-3220-7_15openalex-snapshot

Ileal Interposition with Sleeve Gastrectomy for the Treatment of Type 2 Diabetes

inferred← citeshttps://doi.org/10.1007/978-1-4939-9802-9_7openalex-snapshot

Proteomic Profiling of Human Skeletal Muscle in Health and Disease

inferred← citeshttps://doi.org/10.1007/978-1-60327-357-2_11openalex-snapshot

Global Cardiovascular Risk Reduction in People with Diabetes Mellitus and Hypertension

inferred← citeshttps://doi.org/10.1007/978-1-60761-395-4_29openalex-snapshot

Type II Diabetes Mellitus and Obesity in Youths

inferred← citeshttps://doi.org/10.1007/978-1-61779-894-8_6openalex-snapshot

Medical Nutrition Therapy for Diabetes: Prioritizing Recommendations Based on Evidence

inferred← citeshttps://doi.org/10.1007/978-3-030-11748-1_10openalex-snapshot

Role of Tissue Biopsy in Drug Development for Nonalcoholic Fatty Liver Disease and Other Metabolic Disorders

inferred← citeshttps://doi.org/10.1007/978-3-030-11748-1_2openalex-snapshot

Assessment of Islet Alpha- and Beta-Cell Function

inferred← citeshttps://doi.org/10.1007/978-3-030-11815-0_6openalex-snapshot

Definition, Diagnostic Criteria, Screening, Diagnosis, and Classification of Diabetes and Categories of Glucose Intolerance

inferred← citeshttps://doi.org/10.1007/978-3-030-11815-0_8openalex-snapshot

Pathophysiology of Type 2 Diabetes

inferred← citeshttps://doi.org/10.1007/978-3-030-33286-0_13openalex-snapshot

Demographic Influences and Health Disparities

inferred← citeshttps://doi.org/10.1007/978-3-030-33286-0_18openalex-snapshot

Update on Diabetes Medical Management: Epidemiology and Treatment

inferred← citeshttps://doi.org/10.1007/978-3-030-33286-0_19openalex-snapshot

Biobehavioral Factors Related to the Development and Course of Type 2 Diabetes and Cardiometabolic Impairment in Adults: The Critical Role of Weight, Diet, Physical Activity, and Other Lifestyle Behaviors

inferred← citeshttps://doi.org/10.1007/978-3-030-42634-7_294openalex-snapshot

Diabetes Mellitus

inferred← citeshttps://doi.org/10.1007/978-3-030-45103-5_23openalex-snapshot

Type II Diabetes Mellitus

inferred← citeshttps://doi.org/10.1007/978-3-030-53370-0_61openalex-snapshot

Relapse of Diabetes After Metabolic/Bariatric Surgery

inferred← citeshttps://doi.org/10.1007/978-3-030-62632-7_1openalex-snapshot

Cardiovascular Disease Epidemiology and Risk Factors: General Concepts

inferred← citeshttps://doi.org/10.1007/978-3-030-92196-5_1openalex-snapshot

Obesity and Diabetes

inferred← citeshttps://doi.org/10.1007/978-3-030-98927-9_13openalex-snapshot

Precision Exercise and Physical Activity for Diabetes

inferred← citeshttps://doi.org/10.1007/978-3-031-13009-0_26openalex-snapshot

Diabetogenic Effects of Antihypertensive Drugs and Statins

inferred← citeshttps://doi.org/10.1007/978-3-031-13177-6_12openalex-snapshot

The Metabolic Syndrome and Vascular Disease

inferred← citeshttps://doi.org/10.1007/978-3-031-13177-6_33openalex-snapshot

SGLT2 Inhibitors and GLP1 Antagonists on Diabetes and Cardiovascular Disease

inferred← citeshttps://doi.org/10.1007/978-3-031-13177-6_8openalex-snapshot

Adiponectin, Diabetes, and the Cardiovascular System

inferred← citeshttps://doi.org/10.1007/978-3-031-15353-2_7openalex-snapshot

Diabetes

inferred← citeshttps://doi.org/10.1007/978-3-031-16258-9_8openalex-snapshot

Diabetes Mellitus in Acromegaly

inferred← citeshttps://doi.org/10.1007/978-3-031-25519-9_6openalex-snapshot

Definition, Diagnostic Criteria, Screening, Diagnosis, and Classification of Diabetes and Categories of Glucose Intolerance: An Update

inferred← citeshttps://doi.org/10.1007/978-3-031-25519-9_9openalex-snapshot

Pathophysiology of Type 2 Diabetes

inferred← citeshttps://doi.org/10.1007/978-3-031-82232-2_40openalex-snapshot

Prediabetes, Diabetes and Peripheral Arterial Disease

inferred← citeshttps://doi.org/10.1007/978-3-031-86558-9_25openalex-snapshot

Physical Therapist Management of Diabetes Mellitus

inferred← citeshttps://doi.org/10.1007/978-3-032-24854-1_12openalex-snapshot

Prediabetes and Digital Tools

inferred← citeshttps://doi.org/10.1007/978-3-032-26472-5_10openalex-snapshot

Sex Differences in the Effects of Lifestyle Interventions on Cardiovascular Disease Risk

inferred← citeshttps://doi.org/10.1007/978-3-319-05257-1_2012openalex-snapshot

Diabetes Mellitus: Diagnosis and Care

inferred← citeshttps://doi.org/10.1007/978-3-319-08982-9_1openalex-snapshot

Introduction and disease overview

inferred← citeshttps://doi.org/10.1007/978-3-319-09915-6_15openalex-snapshot

Dynamic Leptin Secretion in Obesity and Diabetes

inferred← citeshttps://doi.org/10.1007/978-3-319-10939-8_4openalex-snapshot

Insulin Management in Type 2 Diabetes

inferred← citeshttps://doi.org/10.1007/978-3-319-13126-9_10openalex-snapshot

Pharmacologic Approach to Type 2 Diabetes in Obese Patients

inferred← citeshttps://doi.org/10.1007/978-3-319-18741-9_34openalex-snapshot

Insulin Resistance and the Metabolic Syndrome

inferred← citeshttps://doi.org/10.1007/978-3-319-18741-9_44openalex-snapshot

Treating Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1007/978-3-319-20317-1_14-1openalex-snapshot

Diabetes in Older Adults

inferred← citeshttps://doi.org/10.1007/978-3-319-20789-6_12-1openalex-snapshot

Diabetes Mellitus: Diagnosis and Care

inferred← citeshttps://doi.org/10.1007/978-3-319-20789-6_12-2openalex-snapshot

Diabetes Mellitus: Diagnosis and Care

inferred← citeshttps://doi.org/10.1007/978-3-319-20797-1_34-1openalex-snapshot

Insulin Resistance and the Metabolic Syndrome

inferred← citeshttps://doi.org/10.1007/978-3-319-20797-1_34-2openalex-snapshot

Insulin Resistance and the Metabolic Syndrome

inferred← citeshttps://doi.org/10.1007/978-3-319-20797-1_44-1openalex-snapshot

Treating Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1007/978-3-319-20797-1_44-2openalex-snapshot

Treating Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1007/978-3-319-23246-1_12openalex-snapshot

Diabetes and Aging

inferred← citeshttps://doi.org/10.1007/978-3-319-25787-7_9openalex-snapshot

Endocrine Disorders

inferred← citeshttps://doi.org/10.1007/978-3-319-27317-4_1-1openalex-snapshot

Overview of Glucose Homeostasis

inferred← citeshttps://doi.org/10.1007/978-3-319-27317-4_19-1openalex-snapshot

Treatment with Oral Drugs

inferred← citeshttps://doi.org/10.1007/978-3-319-27317-4_20-1openalex-snapshot

Treatment with GLP-1 Receptor Agonists

inferred← citeshttps://doi.org/10.1007/978-3-319-27317-4_21-1openalex-snapshot

Insulin Treatment

inferred← citeshttps://doi.org/10.1007/978-3-319-27317-4_8-1openalex-snapshot

Pathogenesis of Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1007/978-3-319-32700-6_49-1openalex-snapshot

Diabetes Mellitus in the Elderly

inferred← citeshttps://doi.org/10.1007/978-3-319-33434-9_49openalex-snapshot

Diabetes Mellitus in the Elderly

inferred← citeshttps://doi.org/10.1007/978-3-319-41559-8_2openalex-snapshot

Primary Prevention of Type 2 Diabetes: An Imperative for Developing Countries

inferred← citeshttps://doi.org/10.1007/978-3-319-43296-0_1openalex-snapshot

Overview of Type 2 Diabetes

inferred← citeshttps://doi.org/10.1007/978-3-319-45015-5_19openalex-snapshot

Treatment with Oral Drugs

inferred← citeshttps://doi.org/10.1007/978-3-319-45015-5_20openalex-snapshot

Treatment with GLP-1 Receptor Agonists

inferred← citeshttps://doi.org/10.1007/978-3-319-45015-5_21openalex-snapshot

Insulin Treatment

inferred← citeshttps://doi.org/10.1007/978-3-319-45015-5_8openalex-snapshot

Pathogenesis of Type 2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1007/978-3-319-47771-8_14openalex-snapshot

Diabetes in Older Adults

inferred← citeshttps://doi.org/10.1007/978-3-319-52031-5_6openalex-snapshot

The Physiological Significance of Brown Adipose Tissue and the Beiging of White Adipose Tissue in People

inferred← citeshttps://doi.org/10.1007/978-3-319-55330-6_25openalex-snapshot

Insulin Resistance and Mitochondrial Dysfunction

inferred← citeshttps://doi.org/10.1007/978-3-319-58868-1_20openalex-snapshot

Endocrine Disorders and Maxillofacial Surgery

inferred← citeshttps://doi.org/10.1007/978-3-319-61401-4_8openalex-snapshot

Imaging in Diabetes

inferred← citeshttps://doi.org/10.1007/978-3-319-68192-4_24openalex-snapshot

Youth-Onset Type 2 Diabetes

inferred← citeshttps://doi.org/10.1007/978-3-319-68379-9_6openalex-snapshot

Diabetes

inferred← citeshttps://doi.org/10.1007/978-3-319-90495-5_294-1openalex-snapshot

Diabetes Mellitus

inferred← citeshttps://doi.org/10.1007/978-3-319-95828-6_4openalex-snapshot

NAFLD and Insulin Resistance: A Multisystemic Disease

inferred← citeshttps://doi.org/10.1007/978-3-319-98890-0_4openalex-snapshot

Fetal Programming of Fatty Liver Disease

inferred← citeshttps://doi.org/10.1007/978-3-642-14285-7_5openalex-snapshot

Endokrine Tumoren des gastroenteropankreatischen Systems

inferred← citeshttps://doi.org/10.1007/978-3-642-17214-4_1openalex-snapshot

Targeting Type 2 Diabetes

inferred← citeshttps://doi.org/10.1007/978-3-642-17214-4_2openalex-snapshot

Dual Acting and Pan-PPAR Activators as Potential Anti-diabetic Therapies

inferred← citeshttps://doi.org/10.1007/978-3-642-41358-2_4openalex-snapshot

Typ-2-Diabetes

inferred← citeshttps://doi.org/10.1007/978-94-007-5971-8_3openalex-snapshot

Diabetes Mellitus: New Challenges and Innovative Therapies

inferred← citeshttps://doi.org/10.1007/978-981-10-2705-5_20openalex-snapshot

Perioperative Management of Medical Comorbidities After Bariatric Surgery

inferred← citeshttps://doi.org/10.1007/978-981-10-5804-2_9openalex-snapshot

Diabetics and Stroke

inferred← citeshttps://doi.org/10.1007/978-981-13-6920-9_11openalex-snapshot

Screening of Natural Antidiabetic Agents

inferred← citeshttps://doi.org/10.1007/978-981-19-0027-3_6openalex-snapshot

Technology in the Management of Type 1 and Type 2 Diabetes Mellitus: Recent Status and Future Prospects

inferred← citeshttps://doi.org/10.1007/978-981-32-9358-8_21openalex-snapshot

Tau, Diabetes and Insulin

inferred← citeshttps://doi.org/10.1007/978-981-32-9393-9_7openalex-snapshot

Diabetes with Pancreatic Ductal Adenocarcinoma

inferred← citeshttps://doi.org/10.1007/978-981-33-6009-9_43openalex-snapshot

Pharmacotherapy of Diabetes Mellitus

inferred← citeshttps://doi.org/10.1007/978-981-33-6350-2_2openalex-snapshot

Search of Sweeteners, Their General Classification, Synthesis, and Saccharide Sweeteners Plant–Animal Interphases

inferred← citeshttps://doi.org/10.1007/978-981-92-0763-3_7openalex-snapshot

Endocrine Control of Metabolism: Hormonal Regulation of Energy Homeostasis

inferred← citeshttps://doi.org/10.1007/978-981-97-6406-8_21openalex-snapshot

Adverse Events Due to Oral Hypoglycemic Drugs

inferred← citeshttps://doi.org/10.1007/978-981-97-7568-2_8openalex-snapshot

Exploring the Current Selective Drugs of SGLT2 Inhibitors for the Treatment of Cardiovascular Disease in Type 2 Diabetes

inferred← citeshttps://doi.org/10.1007/bf03346697openalex-snapshot

New therapeutic algorithm of Type 2 diabetes: Lights and shadows

inferred← citeshttps://doi.org/10.1007/s00018-022-04677-5openalex-snapshot

Pharmacological and mechanistic study of PS1, a Pdia4 inhibitor, in β-cell pathogenesis and diabetes in db/db mice

inferred← citeshttps://doi.org/10.1007/s00125-009-1443-3openalex-snapshot

Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?

inferred← citeshttps://doi.org/10.1007/s00125-009-1614-2openalex-snapshot

Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study

inferred← citeshttps://doi.org/10.1007/s00125-010-1684-1openalex-snapshot

Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009

inferred← citeshttps://doi.org/10.1007/s00125-010-1702-3openalex-snapshot

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

inferred← citeshttps://doi.org/10.1007/s00125-010-1767-zopenalex-snapshot

Consensus guidelines, algorithms and care of the individual patient with type 2 diabetes

inferred← citeshttps://doi.org/10.1007/s00125-010-1966-7openalex-snapshot

A novel surrogate index for hepatic insulin resistance

inferred← citeshttps://doi.org/10.1007/s00125-010-1977-4openalex-snapshot

Association of indices of liver and adipocyte insulin resistance with 19 confirmed susceptibility loci for type 2 diabetes in 6,733 non-diabetic Finnish men

inferred← citeshttps://doi.org/10.1007/s00125-011-2085-9openalex-snapshot

The four-variable modification of diet in renal disease formula underestimates glomerular filtration rate in obese type 2 diabetic individuals with chronic kidney disease

inferred← citeshttps://doi.org/10.1007/s00125-011-2130-8openalex-snapshot

RETRACTED ARTICLE: Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease

inferred← citeshttps://doi.org/10.1007/s00125-011-2414-zopenalex-snapshot

Lentivirus shRNA Grb10 targeting the pancreas induces apoptosis and improved glucose tolerance due to decreased plasma glucagon levels

inferred← citeshttps://doi.org/10.1007/s00125-012-2577-2openalex-snapshot

Insulin clearance: confirmation as a highly heritable trait, and genome-wide linkage analysis

inferred← citeshttps://doi.org/10.1007/s00125-012-2589-yopenalex-snapshot

The thrifty phenotype hypothesis revisited

inferred← citeshttps://doi.org/10.1007/s00125-013-2897-xopenalex-snapshot

Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes

showing the first 200 of 2917

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.